+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Carrier Screening Market Research Report by Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Medical Condition, Technology, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 156 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5122367
UP TO OFF until Dec 31st 2022
The United States Carrier Screening Market size was estimated at USD 474.99 million in 2021, USD 572.59 million in 2022, and is projected to grow at a CAGR 16.77% to reach USD 1,204.32 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Carrier Screening to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Expanded Carrier Screening and Targeted Disease Carrier Screening. The Expanded Carrier Screening is further studied across Customized Panel Testing and Predesigned Panel Testing.
  • Based on Medical Condition, the market was studied across Hematological Conditions, Neurological Conditions, and Pulmonary Conditions.
  • Based on Technology, the market was studied across DNA Sequencing, Microarrays, and Polymerase Chain Reaction.
  • Based on End User, the market was studied across Hospitals, Physician Offices and Clinics, and Reference Laboratories.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Carrier Screening market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Carrier Screening Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Carrier Screening Market, including 23Andme Inc., Abbott Laboratories, Autogenomics Inc., BGI, Centogene, Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche AG, Fulgent Genetics Inc, Gene By Gene, Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Medgenome, Myriad Genetics, Natera Inc, Opko Health, Otogenetics Corporation, Pathway Genomics, Progenity, Quest Diagnostics Incorporated, Sema4, Sequenom Inc., Thermo Fisher Scientific Inc, and True Health.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Carrier Screening Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Carrier Screening Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Carrier Screening Market?
4. What is the competitive strategic window for opportunities in the United States Carrier Screening Market?
5. What are the technology trends and regulatory frameworks in the United States Carrier Screening Market?
6. What is the market share of the leading vendors in the United States Carrier Screening Market?
7. What modes and strategic moves are considered suitable for entering the United States Carrier Screening Market?
Frequently Asked Questions about the U.S. Carrier Screening Market

What is the estimated value of the U.S. Carrier Screening Market?

The U.S. Carrier Screening Market was estimated to be valued at $474.99 Million in 2021.

What is the growth rate of the U.S. Carrier Screening Market?

The growth rate of the U.S. Carrier Screening Market is 16.7%, with an estimated value of $1204.32 Million by 2027.

What is the forecasted size of the U.S. Carrier Screening Market?

The U.S. Carrier Screening Market is estimated to be worth $1204.32 Million by 2027.

Who are the key companies in the U.S. Carrier Screening Market?

Key companies in the U.S. Carrier Screening Market include 23Andme Inc., Abbott Laboratories, Autogenomics Inc., BGI, Centogene, Danaher Corporation, Eurofins Scientific, F. Hoffmann and Fulgent Genetics Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Carrier Screening Market, by Type
6.1. Introduction
6.2. Expanded Carrier Screening
6.2.1. Customized Panel Testing
6.2.2. Predesigned Panel Testing
6.3. Targeted Disease Carrier Screening
7. Carrier Screening Market, by Medical Condition
7.1. Introduction
7.2. Hematological Conditions
7.3. Neurological Conditions
7.4. Pulmonary Conditions
8. Carrier Screening Market, by Technology
8.1. Introduction
8.2. DNA Sequencing
8.3. Microarrays
8.4. Polymerase Chain Reaction
9. Carrier Screening Market, by End User
9.1. Introduction
9.2. Hospitals
9.3. Physician Offices and Clinics
9.4. Reference Laboratories
10. California Carrier Screening Market11. Florida Carrier Screening Market12. Illinois Carrier Screening Market13. New York Carrier Screening Market14. Ohio Carrier Screening Market15. Pennsylvania Carrier Screening Market16. Texas Carrier Screening Market
17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion
18. Company Usability Profiles
18.1. 23Andme Inc.
18.2. Abbott Laboratories
18.3. Autogenomics Inc.
18.4. BGI
18.5. Centogene
18.6. Danaher Corporation
18.7. Eurofins Scientific
18.8. F. Hoffmann-La Roche AG
18.9. Fulgent Genetics Inc
18.10. Gene By Gene
18.11. Illumina Inc.
18.12. Invitae Corporation
18.13. Laboratory Corporation of America Holdings
18.14. Luminex Corporation
18.15. Medgenome
18.16. Myriad Genetics
18.17. Natera Inc
18.18. Opko Health
18.19. Otogenetics Corporation
18.20. Pathway Genomics
18.21. Progenity
18.22. Quest Diagnostics Incorporated
18.23. Sema4
18.24. Sequenom Inc.
18.25. Thermo Fisher Scientific Inc
18.26. True Health
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES CARRIER SCREENING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES CARRIER SCREENING MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES CARRIER SCREENING MARKET DYNAMICS
FIGURE 8. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CARRIER SCREENING MARKET SIZE, BY TYPE, 2027
FIGURE 11. UNITED STATES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES CARRIER SCREENING MARKET SIZE, BY CUSTOMIZED PANEL TESTING, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES CARRIER SCREENING MARKET SIZE, BY CUSTOMIZED PANEL TESTING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES CARRIER SCREENING MARKET SIZE, BY PREDESIGNED PANEL TESTING, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES CARRIER SCREENING MARKET SIZE, BY PREDESIGNED PANEL TESTING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TARGETED DISEASE CARRIER SCREENING, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TARGETED DISEASE CARRIER SCREENING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2021 VS 2027 (%)
FIGURE 20. UNITED STATES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2021 VS 2027 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2027
FIGURE 22. UNITED STATES CARRIER SCREENING MARKET SIZE, BY HEMATOLOGICAL CONDITIONS, 2019-2027 (USD MILLION)
FIGURE 23. UNITED STATES CARRIER SCREENING MARKET SIZE, BY HEMATOLOGICAL CONDITIONS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES CARRIER SCREENING MARKET SIZE, BY NEUROLOGICAL CONDITIONS, 2019-2027 (USD MILLION)
FIGURE 25. UNITED STATES CARRIER SCREENING MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES CARRIER SCREENING MARKET SIZE, BY PULMONARY CONDITIONS, 2019-2027 (USD MILLION)
FIGURE 27. UNITED STATES CARRIER SCREENING MARKET SIZE, BY PULMONARY CONDITIONS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 28. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 29. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 31. UNITED STATES CARRIER SCREENING MARKET SIZE, BY DNA SEQUENCING, 2019-2027 (USD MILLION)
FIGURE 32. UNITED STATES CARRIER SCREENING MARKET SIZE, BY DNA SEQUENCING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 33. UNITED STATES CARRIER SCREENING MARKET SIZE, BY MICROARRAYS, 2019-2027 (USD MILLION)
FIGURE 34. UNITED STATES CARRIER SCREENING MARKET SIZE, BY MICROARRAYS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 35. UNITED STATES CARRIER SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2019-2027 (USD MILLION)
FIGURE 36. UNITED STATES CARRIER SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 37. UNITED STATES CARRIER SCREENING MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 38. UNITED STATES CARRIER SCREENING MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CARRIER SCREENING MARKET SIZE, BY END USER, 2027
FIGURE 40. UNITED STATES CARRIER SCREENING MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 41. UNITED STATES CARRIER SCREENING MARKET SIZE, BY HOSPITALS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 42. UNITED STATES CARRIER SCREENING MARKET SIZE, BY PHYSICIAN OFFICES AND CLINICS, 2019-2027 (USD MILLION)
FIGURE 43. UNITED STATES CARRIER SCREENING MARKET SIZE, BY PHYSICIAN OFFICES AND CLINICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 44. UNITED STATES CARRIER SCREENING MARKET SIZE, BY REFERENCE LABORATORIES, 2019-2027 (USD MILLION)
FIGURE 45. UNITED STATES CARRIER SCREENING MARKET SIZE, BY REFERENCE LABORATORIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 46. CALIFORNIA CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. FLORIDA CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. ILLINOIS CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. NEW YORK CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. OHIO CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. PENNSYLVANIA CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. TEXAS CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. UNITED STATES CARRIER SCREENING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 54. UNITED STATES CARRIER SCREENING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 55. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CARRIER SCREENING MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES CARRIER SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES CARRIER SCREENING MARKET SIZE, BY CUSTOMIZED PANEL TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES CARRIER SCREENING MARKET SIZE, BY PREDESIGNED PANEL TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TARGETED DISEASE CARRIER SCREENING, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES CARRIER SCREENING MARKET SIZE, BY HEMATOLOGICAL CONDITIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES CARRIER SCREENING MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES CARRIER SCREENING MARKET SIZE, BY PULMONARY CONDITIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES CARRIER SCREENING MARKET SIZE, BY DNA SEQUENCING, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES CARRIER SCREENING MARKET SIZE, BY MICROARRAYS, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES CARRIER SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES CARRIER SCREENING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES CARRIER SCREENING MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. UNITED STATES CARRIER SCREENING MARKET SIZE, BY PHYSICIAN OFFICES AND CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES CARRIER SCREENING MARKET SIZE, BY REFERENCE LABORATORIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. CALIFORNIA CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 23. CALIFORNIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 24. CALIFORNIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2019-2027 (USD MILLION)
TABLE 25. CALIFORNIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 26. CALIFORNIA CARRIER SCREENING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 27. FLORIDA CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 28. FLORIDA CARRIER SCREENING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 29. FLORIDA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2019-2027 (USD MILLION)
TABLE 30. FLORIDA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 31. FLORIDA CARRIER SCREENING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 32. ILLINOIS CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 33. ILLINOIS CARRIER SCREENING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 34. ILLINOIS CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2019-2027 (USD MILLION)
TABLE 35. ILLINOIS CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 36. ILLINOIS CARRIER SCREENING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 37. NEW YORK CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. NEW YORK CARRIER SCREENING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 39. NEW YORK CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2019-2027 (USD MILLION)
TABLE 40. NEW YORK CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 41. NEW YORK CARRIER SCREENING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 42. OHIO CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 43. OHIO CARRIER SCREENING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 44. OHIO CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2019-2027 (USD MILLION)
TABLE 45. OHIO CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 46. OHIO CARRIER SCREENING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 47. PENNSYLVANIA CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. PENNSYLVANIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 49. PENNSYLVANIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2019-2027 (USD MILLION)
TABLE 50. PENNSYLVANIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 51. PENNSYLVANIA CARRIER SCREENING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 52. TEXAS CARRIER SCREENING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. TEXAS CARRIER SCREENING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 54. TEXAS CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2019-2027 (USD MILLION)
TABLE 55. TEXAS CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 56. TEXAS CARRIER SCREENING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 57. UNITED STATES CARRIER SCREENING MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 58. UNITED STATES CARRIER SCREENING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 59. UNITED STATES CARRIER SCREENING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 60. UNITED STATES CARRIER SCREENING MARKET RANKING
TABLE 61. UNITED STATES CARRIER SCREENING MARKET SHARE, BY KEY PLAYER, 2021
TABLE 62. UNITED STATES CARRIER SCREENING MARKET MERGER & ACQUISITION
TABLE 63. UNITED STATES CARRIER SCREENING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 64. UNITED STATES CARRIER SCREENING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 65. UNITED STATES CARRIER SCREENING MARKET INVESTMENT & FUNDING
TABLE 66. UNITED STATES CARRIER SCREENING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 67. UNITED STATES CARRIER SCREENING MARKET: LICENSE & PRICING

Companies Mentioned

  • 23Andme Inc.
  • Abbott Laboratories
  • Autogenomics Inc.
  • BGI
  • Centogene
  • Danaher Corporation
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Fulgent Genetics Inc
  • Gene By Gene
  • Illumina Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Luminex Corporation
  • Medgenome
  • Myriad Genetics
  • Natera Inc
  • Opko Health
  • Otogenetics Corporation
  • Pathway Genomics
  • Progenity
  • Quest Diagnostics Incorporated
  • Sema4
  • Sequenom Inc.
  • Thermo Fisher Scientific Inc
  • True Health

Methodology

Loading
LOADING...